NASDAQ · Financial Statements

Generation Bio Co. (GBIO) Financial Statements

$5.34 NASDAQ: GBIO Market Cap $35.98M

Generation Bio Co. most recently reported annual revenue of $20.0M, a net loss of $132.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Generation Bio Co.: net profit was positive in 0 of 7 reported years; operating margin moved from -103594.4% to -715.8%, a shift of +102878.6 percentage points; the most recent year shows a net loss of $132.0M.

Income Statement — 7 Years (USD millions)

Metric2018201920202021202220232024
Revenue$0$0$0$0$0$6.0M$20.0M
Operating Expenses$37.0M$62.0M$81.0M$119.0M$141.0M$144.0M$162.0M
Operating Profit$-37.0M$-62.0M$-81.0M$-119.0M$-141.0M$-139.0M$-142.0M
Operating Margin-103594.4%0.0%0.0%0.0%0.0%-2346.9%-715.8%
Other Income$1.0M$1.0M$1.0M$0$5.0M$12.0M$11.0M
Interest$0$0$1.0M$0$5.0M$0$0
Depreciation$0$2.0M$3.0M$5.0M$5.0M$5.0M$5.0M
Profit Before Tax$-36.0M$-61.0M$-81.0M$-119.0M$-137.0M$-127.0M$-132.0M
Tax$0$0$0$0$0$0$0
Net Profit$-36.0M$-60.0M$-81.0M$-119.0M$-137.0M$-127.0M$-132.0M
EPS$-18.20$-13.10$-29.54$-21.17$-23.51$-19.63$-19.76
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '22Mar '23Jun '23Sep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25
Revenue$0$0$1.0M$2.0M$3.0M$4.0M$4.0M$8.0M$4.0M$9.0M$1.0M$2.0M
Operating Expenses$35.0M$35.0M$35.0M$34.0M$41.0M$82.0M$27.0M$25.0M$28.0M$25.0M$24.0M$23.0M
Operating Profit$-35.0M$-35.0M$-34.0M$-31.0M$-38.0M$-78.0M$-23.0M$-18.0M$-24.0M$-17.0M$-23.0M$-21.0M
Operating Margin0.0%0.0%-3854.4%-1461.2%-1335.0%-1912.6%-569.8%-236.8%-562.6%-190.4%-2995.6%-1348.7%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-32.0M$-32.0M$-31.0M$-28.0M$-35.0M$-75.0M$-20.0M$-15.0M$-21.0M$-15.0M$-21.0M$-6.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-32.0M$-32.0M$-31.0M$-28.0M$-35.0M$-75.0M$-20.0M$-15.0M$-21.0M$-15.0M$-21.0M$-6.0M
EPS$-5.10$-5.30$-4.70$-4.29$-5.33$-11.22$-3.07$-2.29$-3.20$-2.21$-3.12$-0.82

Over the 7 years reported for Generation Bio Co., cash stood at $76.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 5.51 times.

Balance Sheet — 7 Years (USD millions)

Metric2018201920202021202220232024
Total Assets$84.0M$42.0M$294.0M$477.0M$376.0M$375.0M$231.0M
Current Assets$77.0M$18.0M$268.0M$379.0M$287.0M$273.0M$193.0M
Cash$7.0M$15.0M$63.0M$375.0M$93.0M$66.0M$76.0M
Inventory$0$0$0$0$0$0$0
Receivables$1.0M$0$0$0$1.0M$4.0M$2.0M
Fixed Assets$4.0M$22.0M$24.0M$91.0M$81.0M$96.0M$36.0M
Capital Work in Progress$0$0$0$0$0$0$0
Investments$70.0M$2.0M$199.0M$0$186.0M$204.0M$109.0M
Other Assets$0$0$0$0$0$0$0
Total Liabilities$125.0M$141.0M$26.0M$95.0M$94.0M$172.0M$145.0M
Current Liabilities$7.0M$9.0M$11.0M$19.0M$19.0M$40.0M$35.0M
Borrowings$0$0$0$81.0M$82.0M$98.0M$94.0M
Other Liabilities$125.0M$141.0M$26.0M$14.0M$12.0M$74.0M$51.0M
Equity$0$0$0$0$0$0$0
Reserves$-42.0M$-99.0M$268.0M$382.0M$282.0M$203.0M$86.0M

For Generation Bio Co., operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $91.0M; free cash flow was positive in 0 of 7 years.

Cash Flow Statement — 7 Years (USD millions)

Metric2018201920202021202220232024
Operating Cash Flow$-28.0M$-40.0M$-70.0M$-92.0M$-102.0M$-53.0M$-89.0M
Investing Cash Flow$-140.0M$28.0M$-211.0M$187.0M$-201.0M$-17.0M$92.0M
Financing Cash Flow$0$0$0$3.0M$-1.0M$0$0
Net Cash Flow$2.0M$8.0M$48.0M$316.0M$-282.0M$-27.0M$6.0M
Free Cash Flow$-31.0M$-60.0M$-76.0M$-98.0M$-111.0M$-60.0M$-91.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.01
FCF Yield-273.94%
Quick Ratio4.44
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Generation Bio Co. (GBIO) financials — frequently asked questions

What is Generation Bio Co.'s annual revenue?

Generation Bio Co. (GBIO) reported annual revenue of $20.0M in its most recent fiscal year.

What is Generation Bio Co.'s net profit?

Generation Bio Co. (GBIO) reported a net loss of $132.0M in its most recent fiscal year.

What is GBIO EV/EBITDA?

Generation Bio Co.'s enterprise value to EBITDA (EV/EBITDA) ratio is -1.01. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
GBIO Overview GBIO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.